Stay updated on VELIA Clinical Trial: Veliparib in Ovarian Cancer
Sign up to get notified when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.

Latest updates to the VELIA Clinical Trial: Veliparib in Ovarian Cancer page
- Check3 days agoChange DetectedThe page footer software revision is updated from **v3.5.2** to **v3.5.3**, indicating an internal site/version update rather than a change to the study record content.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2. No substantive changes to the study record or its presentation.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.4.2 was added and the previous v3.4.1 revision plus a government funding status notice were removed. This update does not alter core study details or page content.SummaryDifference0.1%

- Check82 days agoChange DetectedA government funding lapse notice with operation-status information was added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

Stay in the know with updates to VELIA Clinical Trial: Veliparib in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.